VivoSim Labs, Inc. (VIVS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.58M
Last updated: Nov 17, 2026 at 11:05 AM ET
VivoSim Labs, Inc. (VIVS) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, VivoSim Labs reported EPS of -$0.03. It beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
VIVS's next report is not on the earnings calendar yet.
Earnings History
Of the 23 quarters below that had an estimate, VIVS beat 19, missed 2 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $51000, up 82.1% from $28000 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2026 | $51000 |
| Jun 30, 2026 | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 14, 2026 | $18000 |
| Mar 31, 2026 | -$2.21 | N/A | N/A | N/A | N/A | -152.4% | N/A | N/A | May 29, 2026 | N/A |
| Dec 31, 2025 | -$1.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 11, 2026 | $26000 |
| Sep 30, 2025 | -$0.98 | -$2.28 | N/A | +57.02% | Beat | N/A | N/A | N/A | Nov 6, 2025 | $28000 |
| Jun 30, 2025 | -$1.14 | -$2.28 | N/A | +50.00% | Beat | N/A | N/A | N/A | Aug 12, 2025 | $37000 |
| Mar 31, 2025 | $4.21 | -$2.28 | N/A | +284.65% | Beat | N/A | N/A | N/A | May 30, 2025 | $51000 |
| Dec 31, 2024 | -$2.28 | -$2.40 | N/A | +5.00% | Beat | N/A | N/A | N/A | Feb 19, 2025 | $26000 |
| Sep 30, 2024 | -$1.68 | -$2.64 | N/A | +36.36% | Beat | N/A | N/A | N/A | Nov 8, 2024 | $30000 |
| Jun 30, 2024 | -$2.76 | -$3.96 | N/A | +30.30% | Beat | N/A | N/A | N/A | Aug 5, 2024 | $39000 |
| Mar 31, 2024 | -$8.04 | -$5.04 | N/A | -59.52% | Miss | N/A | N/A | N/A | May 10, 2024 | $29000 |
| Dec 31, 2023 | -$4.80 | -$4.92 | N/A | +2.44% | Beat | N/A | N/A | N/A | Feb 8, 2024 | $5000 |
| Sep 30, 2023 | -$5.52 | -$5.16 | N/A | -6.98% | Miss | N/A | N/A | N/A | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$5.52 | -$5.52 | N/A | +0.04% | Beat | N/A | N/A | N/A | Aug 10, 2023 | $75000 |
| Mar 31, 2023 | -$10.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 25, 2023 | $213000 |
| Dec 31, 2022 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2023 | $131000 |
| Sep 30, 2022 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2022 | $77000 |
| Jun 30, 2022 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2022 | N/A |
| Mar 31, 2022 | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 26, 2022 | $1.50M |
| Dec 31, 2021 | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2022 | N/A |
| Sep 30, 2021 | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 4, 2021 | N/A |
| Jun 30, 2021 | -$0.34 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 5, 2021 | N/A |
| Mar 31, 2021 | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 20, 2021 | N/A |
| Dec 31, 2020 | -$1.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | N/A |
| Sep 30, 2020 | -$1.36 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | Nov 5, 2020 | N/A |
| Jun 30, 2020 | -$0.02 | -$0.06 | N/A | +66.67% | Beat | N/A | N/A | N/A | Aug 6, 2020 | N/A |
| Mar 31, 2020 | -$0.02 | -$0.05 | N/A | +60.00% | Beat | N/A | N/A | N/A | Jun 10, 2020 | N/A |
| Dec 31, 2019 | -$7.20 | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | Feb 11, 2020 | $298000 |
| Sep 30, 2019 | -$11.42 | -$12.00 | N/A | +4.83% | Beat | N/A | N/A | N/A | Nov 7, 2019 | $1.23M |
| Jun 30, 2019 | -$12.00 | -$12.00 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 8, 2019 | $668000 |
| Mar 31, 2019 | -$275.41 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | May 22, 2019 | $680000 |
| Dec 31, 2018 | -$14.40 | -$15.60 | N/A | +7.69% | Beat | N/A | N/A | N/A | Mar 31, 2019 | $779000 |
| Sep 30, 2018 | -$12.00 | -$16.80 | N/A | +28.57% | Beat | N/A | N/A | N/A | Nov 8, 2018 | $943000 |
| Jun 30, 2018 | -$15.98 | -$19.20 | N/A | +16.77% | Beat | N/A | N/A | N/A | Aug 9, 2018 | $689000 |
| Mar 31, 2018 | -$0.07 | -$0.07 | N/A | 0.00% | In line | N/A | N/A | N/A | May 31, 2018 | $1.10M |
| Dec 31, 2017 | -$16.80 | -$21.60 | N/A | +22.22% | Beat | N/A | N/A | N/A | Mar 31, 2018 | $1.15M |
| Sep 30, 2017 | -$21.60 | -$24.00 | N/A | +10.00% | Beat | N/A | N/A | N/A | Nov 9, 2017 | $1.35M |
| Jun 30, 2017 | -$22.56 | -$24.00 | N/A | +6.00% | Beat | N/A | N/A | N/A | Aug 9, 2017 | $990000 |
| Mar 31, 2017 | -$0.10 | -$0.11 | N/A | +6.98% | Beat | N/A | N/A | N/A | Jun 7, 2017 | $812000 |
| Dec 31, 2016 | -$21.60 | -$22.80 | N/A | +5.26% | Beat | N/A | N/A | N/A | Mar 31, 2017 | $1.15M |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Mar 31, 2026 was -$5.36, after -$2.51 the year before. It was -$67.30 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Mar 31, 2026 | -$5.36 | N/A |
| Mar 31, 2025 | -$2.51 | N/A |
| Mar 31, 2024 | -$23.88 | N/A |
| Mar 31, 2023 | -$11.39 | N/A |
| Mar 31, 2022 | -$1.25 | N/A |
| Mar 31, 2021 | -$3.11 | N/A |
| Mar 31, 2020 | -$30.64 | N/A |
| Mar 31, 2019 | -$317.79 | N/A |
| Mar 31, 2018 | -$61.03 | N/A |
| Mar 31, 2017 | -$67.30 | N/A |
Frequently Asked Questions About VIVS
How often does VIVS beat earnings estimates?
VivoSim Labs beat the EPS estimate in 7 of the 8 most recent quarters that had an estimate, with an average surprise of +50.78%.
VIVS pages: Overview, Earnings, Financials, Competitors